These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34627584)

  • 1. The study of novel inflammatory markers in takayasu arteritis and its correlation with disease activity.
    Pathadan AP; Tyagi S; Gupta MD; M P G; Mahajan S; Kunal S; Mahajan B; Bansal A
    Indian Heart J; 2021; 73(5):640-643. PubMed ID: 34627584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiles of serum cytokine levels in Takayasu arteritis patients: Potential utility as biomarkers for monitoring disease activity.
    Tamura N; Maejima Y; Tezuka D; Takamura C; Yoshikawa S; Ashikaga T; Hirao K; Isobe M
    J Cardiol; 2017 Sep; 70(3):278-285. PubMed ID: 27989502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association between platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with disease activity in Takayasu arteritis patients].
    Li ZQ; Zheng ZH; Du WL; Pang LX; Li Y; Wu ZB; Zhu P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Sep; 46(9):713-718. PubMed ID: 30293378
    [No Abstract]   [Full Text] [Related]  

  • 4. The C-Reactive Protein/Albumin Ratio and Complete Blood Count Parameters as Indicators of Disease Activity in Patients with Takayasu Arteritis.
    Seringec Akkececi N; Yildirim Cetin G; Gogebakan H; Acipayam C
    Med Sci Monit; 2019 Feb; 25():1401-1409. PubMed ID: 30792377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Role of Macrophage Phenotypes and CCL2 in the Pathogenesis of Takayasu Arteritis.
    Kong X; Xu M; Cui X; Ma L; Cheng H; Hou J; Sun X; Ma L; Jiang L
    Front Immunol; 2021; 12():646516. PubMed ID: 34079541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasu's arteritis patients.
    Li J; Wang Y; Wang Y; Wang Y; Yang Y; Zhao J; Li M; Tian X; Zeng X
    Arthritis Res Ther; 2020 Dec; 22(1):285. PubMed ID: 33303010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis.
    Park MC; Lee SW; Park YB; Lee SK
    Rheumatology (Oxford); 2006 May; 45(5):545-8. PubMed ID: 16352633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis.
    Chen R; Ma L; Lv P; Lin J; Li C; Yan Y; Jin X; Dai X; Ji Z; Chen H; Ma L; Sun Y; Jiang L
    Arthritis Res Ther; 2021 Feb; 23(1):63. PubMed ID: 33627173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.
    Tombetti E; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bottazzi B; Bozzolo EP; Greco M; Rovere-Querini P; Baldissera E; Del Maschio A; Mantovani A; De Cobelli F; Sabbadini MG; Manfredi AA
    Arthritis Res Ther; 2014 Nov; 16(6):479. PubMed ID: 25394473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol improves treatment outcome and laboratory parameters in patients with Takayasu arteritis: A randomized double-blind and placebo-controlled trial.
    Shi G; Hua M; Xu Q; Ren T
    Immunobiology; 2017 Feb; 222(2):164-168. PubMed ID: 27771172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR-Based Serum Metabolomics of Patients with Takayasu Arteritis: Relationship with Disease Activity.
    Jain A; Kumar D; Guleria A; Misra DP; Zanwar A; Chaurasia S; Kumar S; Kumar U; Mishra SK; Goel R; Danda D; Misra R
    J Proteome Res; 2018 Sep; 17(9):3317-3324. PubMed ID: 30095916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of contrast-enhanced ultrasonography of the carotid artery for evaluating disease activity in Takayasu arteritis.
    Ma LY; Li CL; Ma LL; Cui XM; Dai XM; Sun Y; Chen HY; Huang BJ; Jiang LD
    Arthritis Res Ther; 2019 Jan; 21(1):24. PubMed ID: 30651132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YKL-40 as a new biomarker of disease activity in Takayasu arteritis.
    Sun Y; Kong X; Wu S; Ma L; Yan Y; Lv P; Jiang L
    Int J Cardiol; 2019 Oct; 293():231-237. PubMed ID: 31303395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases as novel disease markers in Takayasu arteritis.
    Matsuyama A; Sakai N; Ishigami M; Hiraoka H; Kashine S; Hirata A; Nakamura T; Yamashita S; Matsuzawa Y
    Circulation; 2003 Sep; 108(12):1469-73. PubMed ID: 12952836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha -308G/A gene polymorphism and novel biomarker profiles in patients with Takayasu arteritis.
    Sarkar PG; Gupta MD; Girish MP; Bansal A; Kohli S; Saijpaul R; Tyagi S; Pasha Q
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S167-S172. PubMed ID: 30595251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of mean platelet volume in patients with Takayasu arteritis.
    Peng YF; Guo J; Deng YB
    Ann Clin Biochem; 2017 Mar; 54(2):273-278. PubMed ID: 27329216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Biomarkers for Monitoring and Prognosis of Large Vessel Vasculitides.
    Tombetti E; Hysa E; Mason JC; Cimmino MA; Camellino D
    Curr Rheumatol Rep; 2021 Feb; 23(3):17. PubMed ID: 33569633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of N-terminal pro-brain natriuretic peptide in Takayasu arteritis disease monitoring.
    Liu Q; Dang A; Chen B; Lv N; Wang X; Zheng D
    J Rheumatol; 2014 Aug; 41(8):1683-8. PubMed ID: 25028376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?
    Noris M; Daina E; Gamba S; Bonazzola S; Remuzzi G
    Circulation; 1999 Jul; 100(1):55-60. PubMed ID: 10393681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of resistance exercise on treatment outcome and laboratory parameters of Takayasu arteritis with magnetic resonance imaging diagnosis: A randomized parallel controlled clinical trial.
    Li G; Liu F; Wang Y; Zhao M; Song Y; Zhang L
    Clin Cardiol; 2020 Nov; 43(11):1273-1278. PubMed ID: 32761844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.